Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Secukinumab Prefilled Syringes in Chronic Plaque Psoriasis
jRCT2080221919Phase 3
- Sponsor
- Novartis
- Start
- Sep 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of secukinumab in plaque psoriasis, sponsored by Novartis.
02
Drugs
secukinumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on jRCT2080221919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221919.